Published in
Elsevier, The Lancet Regional Health Europe, (28), p. 100613, 2023
DOI: 10.1016/j.lanepe.2023.100613
Links
Tools
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Journal article published in 2023 by
Júlia Corominas 
,
Carme Garriga,
Antoni Prenafeta,
Alexandra Moros ,
Manuel Cañete,
Dàlia Raïch-Regué ,
Antonio Barreiro,
Luis González-González ,
Rachel Abu Taleb ,
Benjamin Trinité ,
Laia Madrenas,
Marçal Gallemí ,
Raúl Pérez-Caballero ,
Julià Blanco,
Irina Güell
and other authors.
,
Carme Garriga,
Antoni Prenafeta,
Alexandra Moros ,
Manuel Cañete,
Dàlia Raïch-Regué ,
Antonio Barreiro,
Luis González-González ,
Rachel Abu Taleb ,
Benjamin Trinité ,
Laia Madrenas,
Marçal Gallemí ,
Raúl Pérez-Caballero ,
Julià Blanco,
Irina Güell
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 